Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

F. Amoruso · SciRah

Researcher profile · Semantic Scholar

F. Amoruso

Share profile

F. Amoruso — researcher profile on SciRah

h-index: 9
Works: 14
Citations: 241

Most-cited papers

Real‐life effectiveness of tildrakizumab in chronic plaque psoriasis: A 52‐week multicentre retrospective study—IL PSO (Italian landscape psoriasis)
A. Narcisi, M. Valenti, L. Gargiulo, L. Ibba +16 more
2022Journal of the European Academy of Dermatology and Venereology50 citations Open access
Semantic Scholar
A risankizumab super responder profile identified by long‐term real‐life observation‐IL PSO (ITALIAN LANDSCAPE PSORIASIS)
L. Gargiulo, L. Ibba, P. Malagoli, F. Amoruso +24 more
2023Journal of the European Academy of Dermatology and Venereology32 citations
Semantic Scholar
Brodalumab for the treatment of plaque psoriasis in a real-life setting: a 3 years multicenter retrospective study—IL PSO (Italian landscape psoriasis)
L. Gargiulo, L. Ibba, P. Malagoli, F. Amoruso +21 more
2023Frontiers in Medicine27 citations Open access
Semantic Scholar
Effectiveness, Tolerability, and Drug Survival of Risankizumab in a Real-World Setting: A Three-Year Retrospective Multicenter Study—IL PSO (ITALIAN LANDSCAPE PSORIASIS)
L. Gargiulo, L. Ibba, P. Malagoli, F. Amoruso +23 more
2024Journal of Clinical Medicine26 citations Open access
Semantic Scholar
A 52-week multicenter retrospective real-world study on effectiveness and safety of dupilumab in children with atopic dermatitis aged from 6 to 11 years
C. Patruno, G. Fabbrocini, Giuseppe Lauletta, V. Boccaletti +48 more
2023Journal of dermatological treatment (Print)24 citations Open access
Semantic Scholar
Comparative effectiveness of tildrakizumab 200 mg versus tildrakizumab 100 mg in psoriatic patients with high disease burden or above 90 kg of body weight: a 16-week multicenter retrospective study – IL PSO (Italian landscape psoriasis)
L. Gargiulo, L. Ibba, Ruggero Cascio Ingurgio, P. Malagoli +37 more
2024Journal of dermatological treatment (Print)19 citations Open access
Semantic Scholar
Real life long‐term efficacy and safety of ixekizumab in moderate‐to‐severe psoriasis: A 192 weeks multicentric retrospective study—IL PSO (Italian landscape psoriasis)
P. Malagoli, P. Dapavo, G. Pavia, F. Amoruso +13 more
2022Dermatologic Therapy17 citations Open access
Semantic Scholar
Long-Term Effectiveness and Safety of Ixekizumab for the Treatment of Moderate-to-Severe Plaque Psoriasis: A Five-Year Multicenter Retrospective Study—IL PSO (Italian Landscape Psoriasis)
M. Valenti, L. Gargiulo, L. Ibba, P. Malagoli +19 more
2024Dermatologic Therapy13 citations Open access
Semantic Scholar
Short-term effectiveness and safety of abrocitinib in adults with moderate-to-severe atopic dermatitis: results from a 16-week real-world multicenter retrospective study – il AD (Italian landscape atopic dermatitis)
L. Gargiulo, L. Ibba, A. Alfano, P. Malagoli +32 more
2024Journal of dermatological treatment (Print)11 citations Open access
Semantic Scholar
Upadacitinib improves symptoms of concomitant allergic rhinitis or allergic asthma in patients with severe atopic dermatitis: A 16‐week multicentre retrospective study
L. Gargiulo, L. Ibba, F. Piscazzi, F. Amoruso +24 more
2024Journal of the European Academy of Dermatology and Venereology9 citations
Semantic Scholar
Risankizumab: Daily Practice Experience of High Need Patients
A. Brunasso, M. Burlando, F. Amoruso, L. Arancio +4 more
2023Biomedicines5 citations Open access
Semantic Scholar
Long‐term effectiveness and tolerability of apremilast in patients with moderate‐to‐severe plaque psoriasis: A 5‐year multicentre retrospective study—IL PSO (Italian landscape psoriasis)
L. Gargiulo, L. Ibba, P. Malagoli, F. Amoruso +17 more
2024Journal of the European Academy of Dermatology and Venereology4 citations
Semantic Scholar
Effectiveness and Safety of Upadacitinib in Patients with Moderate-to-Severe Atopic Dermatitis and Previous Failures of Th2 Biologics: A Propensity Score-Matched Study.
F. Barei, Alessandra Chiei-Gallo, A. Narcisi, R. C. Ingurgio +35 more
2025Clincal and Experimental Dermatology3 citations Open access
Semantic Scholar
Efficacy and Safety of Abrocitinib for Moderate-to-severe Atopic Dermatitis in Adults: A 52-week Real-world Multicentre Study- IL-AD (Italian Landscape Atopic Dermatitis)
E. Pezzolo, Mariateresa Rossi, Raul Armando Luyo Saboya, P. Malagoli +31 more
2026Acta Dermato-Venereologica1 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Narcisi×12
Invite
A. Narcisi — researcher profile on SciRah
L. Gargiulo×10
Invite
L. Gargiulo — researcher profile on SciRah
P. Malagoli×10
Invite
P. Malagoli — researcher profile on SciRah
A. Balato×10
Invite
A. Balato — researcher profile on SciRah

×9

Invite

L. Ibba — researcher profile on SciRah

Invite

M. Burlando — researcher profile on SciRah

Invite

P. Dapavo — researcher profile on SciRah

F. Loconsole×8

Invite

F. Loconsole — researcher profile on SciRah

M. Travaglini×8

Invite

M. Travaglini — researcher profile on SciRah

Invite

M. Maurelli — researcher profile on SciRah

Invite

V. Dini — researcher profile on SciRah

Invite

F. Gaiani — researcher profile on SciRah